Literature DB >> 696446

Combined chemotherapy with VM 26 and BCNU for recurrent malignant gliomas after operation and irradiation.

E Zander, N de Tribolet, L Wagenknecht.   

Abstract

The preliminary results of a combined chemotherapy trial with VM 26 and BCNU for recurrent malignant gliomas are presented. Four patients out of seven responded favourably to this treatment. Toxicity was mild and reversible.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 696446     DOI： 10.1007/BF01406635

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN： 0001-6268            Impact factor:   2.216


  9 in total

1.  Long-term survival of patients treated with BCNU for brain tumors.

Authors:  J Calogero; D C Crafts; C B Wilson; E B Boldrey; A Rosenberg; K J Enot
Journal:  J Neurosurg       Date:  1975-08       Impact factor: 5.115

2.  Toxicity study of BCNU (NSC-409962) given orally.

Authors:  H E Lessner; W R Vogler
Journal:  Cancer Chemother Rep       Date:  1974 May-Jun

Review 3.  Nitrosoureas in central nervous system tumors.

Authors:  M D Walker
Journal:  Cancer Chemother Rep 3       Date:  1973-05

4.  1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors.

Authors:  C B Wilson; E B Boldrey; K J Enot
Journal:  Cancer Chemother Rep       Date:  1970-08

5.  Comparison of postoperative irradiation alone and in combination with BCNU (NSC-409962) in the management of malignant gliomas.

Authors:  S A Armentrout; E Foltz; H Vermund; P T Otis
Journal:  Cancer Chemother Rep       Date:  1974 Nov-Dec

6.  Proceedings: 4'-Demethyl-epipodophyllotoxin-beta-D-thenylidene-glucoside (PTG) in the treatment of malignant intracranial neoplasms.

Authors:  B D Sklansky; R S Mann-Kaplan; A F Reynolds; M L Rosenblum; M D Walker
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

7.  The effects of 1,3-bis(2-chloroethyl)-1-nitrosurea on survival and cell progression in Chinese hamster cells.

Authors:  S C Barranco; R M Humphrey
Journal:  Cancer Res       Date:  1971-02       Impact factor: 12.701

Review 8.  A pharmacologic basis for brain tumor chemotherapy.

Authors:  V A Levin
Journal:  Semin Oncol       Date:  1975-03       Impact factor: 4.929

9.  BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.

Authors:  M D Walker; B S Hurwitz
Journal:  Cancer Chemother Rep       Date:  1970-08
  9 in total
  2 in total

Review 1.  Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.

Authors:  M S Mahaley
Journal:  J Neurooncol       Date:  1991-10       Impact factor: 4.130

Review 2.  Chemotherapy of malignant gliomas.

Authors:  Y Ushio; T Hayakawa; H Hasegawa; K Yamada; N Arita
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.